Phase I data from the Covid-19 vaccine under development by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13 million people across the globe.
Hackers backed by the Russian state are trying to steal Covid-19 vaccine and treatment research from academic and pharmaceutical institutions around the world, Britain’s National Cyber Security Centre (NCSC) said.
Nanobodies derived from llamas have neutralized the SARS-CoV-2 spike in the lab, effectively neutralizing the virus, according to research from the UK’s Rosalind Franklin Institute.
A University of Washington model projects the U.S. death toll from COVID-19 will climb to just above 224,000 by Nov. 1, up 16,000 from a prior forecast, due to rising infections and hospitalizations in many states.
The U.S. coronavirus outbreak crossed a grim milestone of over 3 million confirmed cases as more states reported record numbers of new infections, and Florida faced an impending shortage of intensive care unit hospital beds.
Researchers at the The Scripps Research Institute found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.
Biotech and pharmaceutical companies and health care institutions are on the front lines of not only fighting COVID-19, but working to develop vaccines and therapies against the respiratory illness – often in unexpected ways.
In order to generate more shots on goal in the development of a vaccine for COVID-19, the U.S. government will provide funds for the development of three vaccine programs against the disease.
University of Washington researchers estimated that 145,728 people could die of COVID-19 in the United States by August 2020.
Less than one month after the White House zeroed in on 14 vaccine candidates for COVID-19, the administration narrowed that list to five potential treatments for the prevention of the novel coronavirus.